Trinity Biotech
TRIB
27 hedge funds and large institutions have $673K invested in Trinity Biotech in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 7 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
119% more call options, than puts
Call options by funds: $57K | Put options by funds: $26K
4% less funds holding
Funds holding: 28 → 27 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
76% less capital invested
Capital invested by funds: $2.81M → $673K (-$2.13M)
82.03% less ownership
Funds ownership: 119.67% → 37.64% (-82%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WN
Williams & Novak
Westlake Village,
California
|
+$79.9K |
| 2 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
+$38.8K |
| 3 |
IWA
Inspirion Wealth Advisors
Libertyville,
Illinois
|
+$14.7K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14K |
| 5 |
LPL Financial
San Diego,
California
|
+$12.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$1.86M |
| 2 |
Renaissance Technologies
New York
|
-$149K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$38.7K |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$28.3K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$13K |
TRIB Hedge Fund Activity: Q4 2025 in Review
27 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q4 2025, worth a combined $673K — down 76% from $2.81M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of TRIB and 6 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 9 added.
The largest buyer was Williams & Novak, adding an estimated $79.9K. The largest seller was Perceptive Advisors, exiting entirely with an estimated $1.86M sold.
- 27 institutional investors held Trinity Biotech (TRIB) as of Q4 2025, down from 28 in Q3 2025.
- Funds reported $673K of Trinity Biotech stock for Q4 2025, down 76% quarter-over-quarter.
- 6 funds opened new Trinity Biotech positions in Q4 2025 and 7 closed out, a net change of -1 holder.
- The largest Trinity Biotech buyer in Q4 2025 was Williams & Novak, an estimated $79.9K added.
- The largest Trinity Biotech seller in Q4 2025 was Perceptive Advisors, an estimated $1.86M sold.
Based on aggregated 13F filings for Q4 2025.